Oralvisc
Natural health product licensed in Canada
- Licence holder
- Medexus Pharmaceuticals Inc.
- NPN or DIN-HM
- 80060413
- Status
- Active licence
- Licence date
- 29 April 2015
- Revision date
- 2 May 2024
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycosaminoglycans Source : Sulfate de dermatane | 8 milligramme | Not calculated |
| Hyaluronate de sodium Source : Hyaluronate de sodium | 60 milligramme | Not calculated |
Non-medicinal ingredients
Acide L-ascorbique, Microcrystalline cellulose, Oxydes de fer, Dioxyde de titane, Gélatine, Stéarate de magnésium, Dioxyde de silicium, Hydrolysat de protéine animale
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support joint health. Helps to reduce joint pain associated with osteoarthritis of the knee. Helps to reduce inflammatory biomarkers associated with osteoarthritis of the knee. Helps to reduce joint pain and improve joint function in osteoarthritis of the knee. Helps to reduce joint discomfort in osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80060413
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging